Condition or disease | Intervention/treatment | Phase |
---|---|---|
Mild Cognitive Impairment | Device: Transcranial Direct Current Stimulation (tDCS) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Supportive Care |
Official Title: | The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment - a Combined MRI and Non-invasive Brain Stimulation Study |
Actual Study Start Date : | February 19, 2020 |
Estimated Primary Completion Date : | May 15, 2021 |
Estimated Study Completion Date : | September 30, 2021 |
Arm | Intervention/treatment |
---|---|
Active Comparator: MCI patients with real transcranial direct current stimulation
Patients will receive 2mA stimulation in 10 consecutive sessions.
|
Device: Transcranial Direct Current Stimulation (tDCS)
2mA stimulation for 20 minutes
|
Sham Comparator: MCI patients with sham transcranial direct current stimulation
Patients will receive sham stimulation in 10 consecutive sessions.
|
Device: Transcranial Direct Current Stimulation (tDCS)
2mA stimulation for 20 minutes
|
Ages Eligible for Study: | 60 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Lubomira Anderková, PhD | +420 549 497 766 | lubomira.anderkova@ceitec.muni.cz | |
Contact: Monika Pupíková, Mgr. | +420 549 498 313 | pupikovam@gmail.com |
Czechia | |
Ceitec, Masaryk University | Recruiting |
Brno, Czechia, 61300 | |
Contact: Monika Pupíková +420549498313 monika.pupikova@ceitec.muni.cz |
Principal Investigator: | Lubomira Anderková, PhD | Ceitec, Masaryk University |
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | May 10, 2019 | ||||||||
First Posted Date ICMJE | June 4, 2019 | ||||||||
Last Update Posted Date | February 20, 2020 | ||||||||
Actual Study Start Date ICMJE | February 19, 2020 | ||||||||
Estimated Primary Completion Date | May 15, 2021 (Final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures ICMJE |
Visual-attention task accuracy [ Time Frame: Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol ] Task will be presented on a computer and subject will respond by YES-NO buttons. Only if there are no differences in task accuracy, we will measure task reaction times (e.g. due to the roof effect).
|
||||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||||
Change History | |||||||||
Current Secondary Outcome Measures ICMJE |
|
||||||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||||||
Current Other Pre-specified Outcome Measures |
|
||||||||
Original Other Pre-specified Outcome Measures | Same as current | ||||||||
Descriptive Information | |||||||||
Brief Title ICMJE | The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment | ||||||||
Official Title ICMJE | The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment - a Combined MRI and Non-invasive Brain Stimulation Study | ||||||||
Brief Summary | Progressively causes the breakdown of cognitive functions and impairs quality of life for patients and their caregivers. In addition to memory impairment, visual attention is also compromised, even at the stage of mild cognitive impairment due to AD (MCI-AD). No treatment has been found for MCI-AD; therefore, attention has been drawn to non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), in order to enhance cognitive functions by modifying brain plasticity. In the current research, investigator aim to examine the long-term effects of the optimal multiple-session tDCS protocol in MCI-AD on visual attention including the transfer to an ecologically valid virtual environment and identify the neural underpinnings of tDCS-induced behavioral aftereffects using a combined tDCS/ MRI network-based approach. | ||||||||
Detailed Description | Investigator will investigate the long-term effects of 10 active tDCS consecutive sessions using an optimized stimulation protocol as compared to a placebo stimulation on visual attention in the MCI-AD. A two-parallel-group, randomized, placebo-controlled design will be used. In addition, the cognitive transfer of tDCS will be evaluated. Repeated tDCS sessions will be performed in 10 consecutive sessions (2 weeks: Monday to Friday) over one preselected ROI together with ongoing visual attention training. During the stimulation, investigator will use the visual matching task. Before the repeated stimulation sessions, participants will undergo the neurocognitive examination. Behavioral examinations of the trained and untrained tasks (i.e. the transfer tasks) will be performed to assess the baseline performance. MRI protocol consisting of T1, T2, FLAIR, and fMRI during the task performance (visual matching task), resting state fMRI, and DTI sequences will be acquired before and after the whole 10-day stimulation protocol in order to search for active vs. placebo tDCS-induced changes in brain activation and resting state functional and structural connectivity and to identify neural correlates of behavioral changes. Behavioral assessment of the trained task and the transfer task will be repeated immediately after and again at a one-month follow-up visit after the end of the last stimulation session | ||||||||
Study Type ICMJE | Interventional | ||||||||
Study Phase ICMJE | Not Applicable | ||||||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Triple (Participant, Investigator, Outcomes Assessor) Primary Purpose: Supportive Care |
||||||||
Condition ICMJE | Mild Cognitive Impairment | ||||||||
Intervention ICMJE | Device: Transcranial Direct Current Stimulation (tDCS)
2mA stimulation for 20 minutes
|
||||||||
Study Arms ICMJE |
|
||||||||
Publications * | Not Provided | ||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status ICMJE | Recruiting | ||||||||
Estimated Enrollment ICMJE |
40 | ||||||||
Original Estimated Enrollment ICMJE | Same as current | ||||||||
Estimated Study Completion Date ICMJE | September 30, 2021 | ||||||||
Estimated Primary Completion Date | May 15, 2021 (Final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||
Sex/Gender ICMJE |
|
||||||||
Ages ICMJE | 60 Years to 85 Years (Adult, Older Adult) | ||||||||
Accepts Healthy Volunteers ICMJE | No | ||||||||
Contacts ICMJE |
|
||||||||
Listed Location Countries ICMJE | Czechia | ||||||||
Removed Location Countries | |||||||||
Administrative Information | |||||||||
NCT Number ICMJE | NCT03974087 | ||||||||
Other Study ID Numbers ICMJE | NV18-04-00256 | ||||||||
Has Data Monitoring Committee | Not Provided | ||||||||
U.S. FDA-regulated Product |
|
||||||||
IPD Sharing Statement ICMJE | Not Provided | ||||||||
Responsible Party | Masaryk University | ||||||||
Study Sponsor ICMJE | Masaryk University | ||||||||
Collaborators ICMJE | St. Anne's University Hospital Brno, Czech Republic | ||||||||
Investigators ICMJE |
|
||||||||
PRS Account | Masaryk University | ||||||||
Verification Date | February 2020 | ||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |